📰 Lobe Sciences News
Page 4 - Lobe Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lobe Sciences. Real-time updates on events, politics, business and more.
September 8, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
September 2, 2022
The Dow closed Thursday up 146 points, 0.5%, at 31,656, while the Nasdaq Composite lost 31 points, 0.3%, to 11,785 and the S&P 500 added 12...
September 2, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
Psychedelics biopharma company Lobe Sciences Ltd. (OTCQB:LOBEF) signed a deal with Cantheon Capital, a development of cannabinoids and psyche...
September 1, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
The Dow closed Thursday up 146 points, 0.5%, at 31,656, while the Nasdaq Composite lost 31 points, 0.3%, to 11,785 and the S&P 500 added 12...
September 1, 2022
“The opportunity to advance our proprietary psilocin compounds in multiple human trials puts Lobe in a leading position within the...
September 1, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
August 19, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
August 10, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering